AbbVie
Lutikizumab
Atopic Dermatitis
Countdown
328days
Phase 2 readout · ~ May 31, 2027 estimated
What's at stake
Phase 2 trial results for Lutikizumab in Atopic Dermatitis are due ~ May 31, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT06718101: Phase 2 trial, sponsor AbbVie, drug Lutikizumab. Primary completion date 2027-05 (estimated).”